Lannett reported $77.92M in Cash and Equivalent for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Amerisourcebergen ABC:US USD 3.39B 353.96M
Ani Pharmaceuticals ANIP:US USD 56.28M 7.1M
Aurora Cannabis Inc ACB:CN CAD 369.28M 68.53M
Canopy Growth Corp WEED:CN CAD 318.43M 6.29M
Cardinal Health CAH:US USD 3.49B 1.23B
Corcept Therapeutics CORT:US USD 50.24M 14.9M
Depomed DEPO:US USD 64.83M 12.56M
Endo International Ordinary Shares ENDP:US USD 1.05B 137.68M
Jazz Pharmaceuticals JAZZ:US USD 482.67M 191.74M
Knight Therapeutics Inc GUD:CN CAD 4.27M 5.53M
Lannett LCI:US USD 77.92M 9.94M
Ligand Pharmaceuticals LGND:US USD 121.41M 116.13M
Mckesson MCK:US USD 2.92B 683M
Nektar Therapeutics NKTR:US USD 105.76M 28.21M
Novartis NVS:US USD 8.73B 5.1B
Omeros OMER:US USD 145.53M 131.4M
Pacira Pharmaceuticals PCRX:US USD 109.42M 12.64M
Perrigo Ordinary Shares PRGO:US USD 468.7M 16.6M
Phibro Animal Health PAHC:US USD 76.28M 2.03M
Prestige Brands PBH:US USD 42.44M 6.57M
Supernus Pharmaceuticals SUPN:US USD 111.49M 61.94M
Teva Pharmaceutical TEVA:IT USD 2.22B 167M
Zoetis ZTS:US USD 2.5B 145M